Human Mycotoxin Biomonitoring: Conclusive Remarks on Direct or Indirect Assessment of Urinary Deoxynivalenol

Overview

Journal Toxins (Basel)

Publisher MDPI

Specialty Toxicology

Date 2020 Feb 28

PMID 32102452

Citations 5

Authors

Arnau Vidal

Nabila Bouzaghnane

Sarah De Saeger

Marthe De Boevre

Affiliations

Soon will be listed here.

Abstract

Deoxynivalenol is one of the most ubiquitous mycotoxins in the Western diet through its presence in cereals and cereal products. A vast amount of studies indicate the worrying level of exposure to this toxin, while even high percentages of the population exceed the tolerable daily intake. To evaluate and assess dietary exposure, analysis of urinary levels of deoxynivalenol and its glucuronides has been proposed as a reliable methodology. An indirect preliminary method was used based on the cleavage of deoxynivalenol glucuronides through the use of enzymes (β-glucuronidase) and subsequent determination of "total deoxynivalenol" (sum of free and released mycotoxins by hydrolysis). Next, a direct procedure for quantification of deoxynivalenol-3-glucuronide and deoxynivalenol-15-glucuronide was developed. As deoxynivalenol glucuronides reference standards are not commercially available, the indirect method is widely applied. However, to not underestimate the total deoxynivalenol exposure in urine, the direct and indirect methodologies need to be compared. Urinary samples (n = 96) with a confirmed presence of deoxynivalenol and/or deoxynivalenol glucuronides were analysed using both approaches. The indirect method clarified that not all deoxynivalenol glucuronides were transformed to free deoxynivalenol during enzymatic treatment, causing an underestimation of total deoxynivalenol. This short communication concludes on the application of direct or indirect assessment of urinary deoxynivalenol.

Citing Articles

Current Advances, Research Needs and Gaps in Mycotoxins Biomonitoring under the HBM4EU-Lessons Learned and Future Trends.

Alvito P, Assuncao R, Bajard L, Martins C, Mengelers M, Mol H Toxins (Basel). 2022; 14(12).

PMID: 36548723 PMC: 9783896. DOI: 10.3390/toxins14120826.

Emetic Response to T-2 Toxin Correspond to Secretion of Glucagon-like Peptide- Amide and Glucose-Dependent Insulinotropic Polypeptide.

Zhang J, Li T, Wu Q, Qin Z, Wei B, Wu R Toxins (Basel). 2022; 14(6).

PMID: 35737050 PMC: 9228683. DOI: 10.3390/toxins14060389.

Neurotoxic Potential of Deoxynivalenol in Murine Brain Cell Lines and Primary Hippocampal Cultures.

Faeste C, Solhaug A, Gaborit M, Pierre F, Massotte D Toxins (Basel). 2022; 14(1).

PMID: 35051025 PMC: 8778863. DOI: 10.3390/toxins14010048.

Modelling the Renal Excretion of the Mycotoxin Deoxynivalenol in Humans in an Everyday Situation.

van den Brand A, Hoogenveen R, Mengelers M, Zeilmaker M, Eriksen G, Uhlig S Toxins (Basel). 2021; 13(10).

PMID: 34678968 PMC: 8540402. DOI: 10.3390/toxins13100675.

Biomonitoring of Multiple Mycotoxins in Urine by GC-MS/MS: A Pilot Study on Patients with Esophageal Cancer in Golestan Province, Northeastern Iran.

Niknejad F, Escriva L, Adel Rad K, Khoshnia M, Barba F, Berrada H Toxins (Basel). 2021; 13(4).

PMID: 33805401 PMC: 8065391. DOI: 10.3390/toxins13040243.

References

Wells L, Hardie L, Williams C, White K, Liu Y, De Santis B . Determination of Deoxynivalenol in the Urine of Pregnant Women in the UK. Toxins (Basel). 2016; 8(11). PMC: 5127103. DOI: 10.3390/toxins8110306. View

Vidal A, Mengelers M, Yang S, De Saeger S, De Boevre M . Mycotoxin Biomarkers of Exposure: A Comprehensive Review. Compr Rev Food Sci Food Saf. 2020; 17(5):1127-1155. DOI: 10.1111/1541-4337.12367. View

Rodriguez-Carrasco Y, Molto J, Manes J, Berrada H . Development of microextraction techniques in combination with GC-MS/MS for the determination of mycotoxins and metabolites in human urine. J Sep Sci. 2017; 40(7):1572-1582. DOI: 10.1002/jssc.201601131. View

Wallin S, Gambacorta L, Kotova N, Lemming E, Nalsen C, Solfrizzo M . Biomonitoring of concurrent mycotoxin exposure among adults in Sweden through urinary multi-biomarker analysis. Food Chem Toxicol. 2015; 83:133-9. DOI: 10.1016/j.fct.2015.05.023. View

Payros D, Dobrindt U, Martin P, Secher T, Bracarense A, Boury M . The Food Contaminant Deoxynivalenol Exacerbates the Genotoxicity of Gut Microbiota. mBio. 2017; 8(2). PMC: 5350463. DOI: 10.1128/mBio.00007-17. View

Bensassi F, El Golli-Bennour E, Abid-Essefi S, Bouaziz C, Hajlaoui M, Bacha H . Pathway of deoxynivalenol-induced apoptosis in human colon carcinoma cells. Toxicology. 2009; 264(1-2):104-9. DOI: 10.1016/j.tox.2009.07.020. View

Deng C, Li C, Zhou S, Wang X, Xu H, Wang D . Risk assessment of deoxynivalenol in high-risk area of China by human biomonitoring using an improved high throughput UPLC-MS/MS method. Sci Rep. 2018; 8(1):3901. PMC: 5832810. DOI: 10.1038/s41598-018-22206-y. View

Vidal A, Claeys L, Mengelers M, Vanhoorne V, Vervaet C, Huybrechts B . Humans significantly metabolize and excrete the mycotoxin deoxynivalenol and its modified form deoxynivalenol-3-glucoside within 24 hours. Sci Rep. 2018; 8(1):5255. PMC: 5869592. DOI: 10.1038/s41598-018-23526-9. View

Warth B, Sulyok M, Berthiller F, Schuhmacher R, Krska R . New insights into the human metabolism of the Fusarium mycotoxins deoxynivalenol and zearalenone. Toxicol Lett. 2013; 220(1):88-94. DOI: 10.1016/j.toxlet.2013.04.012. View

10.

Solfrizzo M, Gambacorta L, Visconti A . Assessment of multi-mycotoxin exposure in southern Italy by urinary multi-biomarker determination. Toxins (Basel). 2014; 6(2):523-38. PMC: 3942749. DOI: 10.3390/toxins6020523. View

11.

Fuchs E, Binder E, Heidler D, Krska R . Structural characterization of metabolites after the microbial degradation of type A trichothecenes by the bacterial strain BBSH 797. Food Addit Contam. 2002; 19(4):379-86. DOI: 10.1080/02652030110091154. View

12.

Lattanzio V, Solfrizzo M, De Girolamo A, Chulze S, Torres A, Visconti A . LC-MS/MS characterization of the urinary excretion profile of the mycotoxin deoxynivalenol in human and rat. J Chromatogr B Analyt Technol Biomed Life Sci. 2011; 879(11-12):707-15. DOI: 10.1016/j.jchromb.2011.01.029. View

13.

Turner P, Burley V, Rothwell J, White K, Cade J, Wild C . Dietary wheat reduction decreases the level of urinary deoxynivalenol in UK adults. J Expo Sci Environ Epidemiol. 2007; 18(4):392-9. DOI: 10.1038/sj.jes.7500611. View

14.

Papageorgiou M, Wells L, Williams C, White K, De Santis B, Liu Y . Assessment of Urinary Deoxynivalenol Biomarkers in UK Children and Adolescents. Toxins (Basel). 2018; 10(2). PMC: 5848151. DOI: 10.3390/toxins10020050. View

15.

Srey C, Kimanya M, Routledge M, Shirima C, Gong Y . Deoxynivalenol exposure assessment in young children in Tanzania. Mol Nutr Food Res. 2014; 58(7):1574-80. DOI: 10.1002/mnfr.201400012. View

16.

Turner P, White K, Burley V, Hopton R, Rajendram A, Fisher J . A comparison of deoxynivalenol intake and urinary deoxynivalenol in UK adults. Biomarkers. 2010; 15(6):553-62. DOI: 10.3109/1354750X.2010.495787. View

17.

Ali N, Blaszkewicz M, Degen G . Assessment of deoxynivalenol exposure among Bangladeshi and German adults by a biomarker-based approach. Toxicol Lett. 2016; 258:20-28. DOI: 10.1016/j.toxlet.2016.06.006. View

18.

Ali N, Blaszkewicz M, Nahid A, Rahman M, Degen G . Deoxynivalenol Exposure Assessment for Pregnant Women in Bangladesh. Toxins (Basel). 2015; 7(10):3845-57. PMC: 4626706. DOI: 10.3390/toxins7103845. View

19.

Wilson M, Jiang Y, Villalta P, Stornetta A, Boudreau P, Carra A . The human gut bacterial genotoxin colibactin alkylates DNA. Science. 2019; 363(6428). PMC: 6407708. DOI: 10.1126/science.aar7785. View

20.

Wu Q, Wang X, Yang W, Nussler A, Xiong L, Kuca K . Oxidative stress-mediated cytotoxicity and metabolism of T-2 toxin and deoxynivalenol in animals and humans: an update. Arch Toxicol. 2014; 88(7):1309-26. DOI: 10.1007/s00204-014-1280-0. View